Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury

Clicks: 326
ID: 269392
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #13 of 30 articles by views in intensive care medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Acute kidney injury (AKI) is associated with incremental risk for death and chronic kidney disease and represents a mounting clinical challenge for healthcare professionals. Renal replacement therapy (RRT) use in ICU settings is rising, likely in response to similar trends in AKI, taken together wit …
Reference Key
sm2017intensivecurrent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bagshaw SM;Darmon M;Ostermann M;Finkelstein FO;Wald R;Tolwani AJ;Goldstein SL;Gattas DJ;Uchino S;Hoste EA;Gaudry S;;
Journal intensive care medicine
Year 2017
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/28289816
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine reproducibility of results practice guidelines as topic* acute kidney injury / therapy* critical care / standards* sean m bagshaw critical illness / therapy* pmid:28289816 doi:10.1007/s00134-017-4762-8 michael darmon stephane gaudry renal replacement therapy / standards*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.